Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1073515425
Clinic

Clinica Sierra Vista

Clinica Sierra Vista was paid $21.29M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 98% of everything it billed.

33Billing provider infoCLINICA SIERRA VISTA
BAKERSFIELD, CA 93304
33aNPI1073515425assigned 08/15/2005
28Total paid$21.29M
24GClaims250,824
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in California

Rank by total paid#172 of 826
Median peer was paid$4.05M
This provider vs. median5.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MEAVE, OLGA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201811,506$1.76M
201918,482$2.08M
202032,494$2.57M
202149,614$3.72M
202246,032$3.23M
202344,918$3.52M
2024incomplete47,778$4.42M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 98% 110,773 103,042 $20.97M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity <1% 52,520 44,479 $108K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 7,074 6,547 $61K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity <1% 22,484 19,102 $51K
G0467 Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit <1% 864 794 $13K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 1,801 1,681 $12K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 8,279 7,199 $9K
0011A <1% 200 200 $8K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 2,494 2,303 $8K
0012A <1% 115 115 $7K
90750 <1% 235 190 $7K
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation <1% 2,134 1,859 $4K
59 more codes
90746 <1% 145 $4K
0064A <1% 106 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 634 $3K
90832 Psychotherapy session, about 30 minutes <1% 4,237 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,168 $2K
90686 <1% 397 $2K
99204 Doctor's office visit, new patient (more involved) <1% 727 $2K
90677 <1% 19 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 124 $1K
90715 <1% 107 $1K
81002 <1% 9,166 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,224 $1K
90707 <1% 40 $693.97
90792 Psychiatric diagnostic evaluation with medical services <1% 507 $674.54
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 143 $619.55
90688 <1% 41 $549.88
3078F <1% 3,158 $540.27
81025 <1% 4,243 $533.22
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,921 $326.60
90732 <1% 19 $284.39
99385 <1% 14 $239.31
90651 <1% 50 $208.00
3080F <1% 35 $166.47
99201 <1% 40 $165.04
90734 <1% 21 $160.90
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,306 $150.45
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 47 $147.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,496 $79.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 14 $72.44
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 101 $30.12
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 133 $29.16
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 60 $20.00
90472 Immunization administration, each additional vaccine (list separately) <1% 424 $17.92
85018 <1% 26 $1.89
3077F 0% 263 $0.00
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 0% 15 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 0% 871 $0.00
99173 0% 54 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 12 $0.00
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 0% 14 $0.00
99215 Doctor's office visit, returning patient (complex) 0% 24 $0.00
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 0% 29 $0.00
90658 0% 13 $0.00
3074F 0% 3,675 $0.00
3075F 0% 447 $0.00
3079F 0% 953 $0.00
82962 0% 109 $0.00
36416 0% 13 $0.00
90656 0% 32 $0.00
90739 0% 13 $0.00
91301 0% 26 $0.00
93000 0% 31 $0.00
J3490 Unclassified drugs 0% 83 $0.00
92551 0% 50 $0.00
A9150 Non-prescription drugs 0% 65 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 93 $0.00
91306 0% 17 $0.00
3044F 0% 26 $0.00
90834 Psychotherapy session, about 45 minutes 0% 30 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMEAVE, OLGA (CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under MEAVE, OLGA

Full network →
ProviderLocationPaid
Clinica Sierra VistaBakersfield, CA$64.97M
Clinica Sierra VistaBakersfield, CA$33.77M
Clinica Sierra VistaLamont, CA$29.67M
Clinica Sierra VistaFresno, CA$23.94M
Clinica Sierra VistaBakersfield, CA$23.33M
Clinica Sierra VistaFresno, CA$23.08M
Clinica Sierra VistaBakersfield, CA$17.29M
Clinica Sierra VistaBakersfield, CA$14.66M
Clinica Sierra VistaFresno, CA$14.10M
Clinica Sierra VistaArvin, CA$14.09M
Clinica Sierra VistaLebec, CA$7.87M
Clinica Sierra VistaDelano, CA$7.36M
Clinica Sierra VistaBakersfield, CA$6.28M
Clinica Sierra VistaBakersfield, CA$5.91M
Clinica Sierra VistaFresno, CA$5.86M
Clinica Sierra VistaFresno, CA$5.78M
Clinica Sierra VistaBakersfield, CA$5.55M
Clinica Sierra VistaBakersfield, CA$4.15M
Clinica Sierra VistaFresno, CA$3.75M
Clinica Sierra VistaFresno, CA$3.47M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.